Integrating anti-EGFR therapies in metastatic colorectal cancer

Journal of Gastrointestinal Oncology

Tanios Bekaii-Saab¹  Sigurdis Haraldsdottir¹ 

[1] The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USAThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA

关键词: Epidermal growth factor inhibitors (EGFR inhibitor);    metastatic colorectal cancer (mCRC);    cetuximab;    panitumumab;    KRAS;    targeted therapy;   

DOI  :  10.3978/j.issn.2078-6891.2013.028

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown